C. Ramacci

发表

In vivo growth inhibitory effect of iterative wild-type p53 gene transfer in human head and neck carcinoma xenografts using glucosylated polyethylenimine nonviral vector

F. Guillemin, M. Barberi-Heyob, J. Merlin, 2002, Cancer Gene Therapy.

Optimization of routine KRAS mutation PCR-based testing procedure for rational individualized first-line-targeted therapy selection in metastatic colorectal cancer

A. Leroux, J. Merlin, A. Chretien, 2013, Cancer medicine.

Validation of a phosphoprotein array assay for characterization of human tyrosine kinase receptor downstream signaling in breast cancer.

A. Leroux, T. Bastogne, J. Merlin, 2009, Clinical chemistry.

Evaluation and validation of HPV real-time PCR assay for the detection of HPV DNA in oral cytobrush and FFPE samples

A. Leroux, J. Salleron, J. Merlin, 2018, Scientific Reports.

MTT assays allow quick and reliable measurement of the response of human tumour cells to photodynamic therapy.

J. Merlin, C. Ramacci, F. Guillemin, 1992, European journal of cancer.

Modulation of daunorubicin cellular resistance by combination of P-glycoprotein blockers acting on drug efflux and intracellular drug sequestration in Golgi vesicles.

J. Merlin, C. Ramacci, S. Marchal, 2000, Cytometry.

Modulation of daunorubicin intracellular accumulation in P-glycoprotein expressing MCF-7 human breast adenocarcinoma cells by thermosensitive-liposome encapsulation and hyperthermia.

C. Ramacci, S. Marchal, C. Vigneron, 1995, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Antiproliferative activity of thermosensitive liposome-encapsulated doxorubicin combined with 43 degrees C hyperthermia in sensitive and multidrug-resistant MCF-7 cells.

J. Merlin, C. Ramacci, S. Marchal, 1993, European journal of cancer.

Enhancement of fotemustine (Muphoran®) cytotoxicity by amifostine in malignant melanoma cell lines

J. Merlin, C. Ramacci, S. Marchal, 2002, Anti-cancer drugs.

Radiation could induce p53-independent and cell cycle--unrelated apoptosis in 5-fluorouracil radiosensitized head and neck carcinoma cells.

J. Mirjolet, M. Barberi-Heyob, C. Didelot, 2002, Canadian journal of physiology and pharmacology.

Expression and activation of P38 MAP kinase in invasive ductal breast cancers: correlation with expression of the estrogen receptor, HER2 and downstream signaling phosphorylated proteins.

A. Leroux, J. Merlin, C. Ramacci, 2013, Oncology reports.

Additional value of EGFR downstream signaling phosphoprotein expression to KRAS status for response to anti‐EGFR antibodies in colorectal cancer

A. Lièvre, P. Laurent-Puig, F. Penault-Llorca, 2010, International journal of cancer.

Comparative evaluation of S9788, verapamil, and cyclosporine A in K562 human leukemia cell lines and in P-glycoprotein-expressing samples from patients with hematologic malignancies.

T. Tsuruo, J. Merlin, C. Ramacci, 1994, Blood.

Damaged DNA Binding Protein 2 Plays a Role in Breast Cancer Cell Growth

Lionel Domenjoud, Philippe Becuwe, Sophie Marchal, 2008, PloS one.

Trastuzumab as a preoperative monotherapy does not inhibit HER2 downstream signaling in HER2-positive breast cancer.

M. Campone, J. Salleron, J. Merlin, 2016, Oncology letters.

PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.

J. Merlin, C. Ramacci, P. Becuwe, 2009, Oncology reports.

Clonal Diversity, Measured by Heterogeneity of Ig and TCR Gene Rearrangements, in Some Acute Leukaemias of Childhood is Associated With a More Aggressive Disease

J. Merlin, C. Ramacci, S. Marchal, 1995 .

Influence of S9788, a new modulator of multidrug resistance, on the cellular accumulation and subcellular distribution of daunorubicin in P-glycoprotein-expressing MCF7 human breast adenocarcinoma cells.

Alain Dieterlen, Sophie Marchal, Maryse Berlion, 1995, Cytometry.

P53 and PTEN expression contribute to the inhibition of EGFR downstream signaling pathway by cetuximab

C. Ramacci, J. Merlin, S. Marchal, 2009, Cancer Gene Therapy.

Oncoprotein expression of E6 and E7 does not prevent 5-fluorouracil (5FU) mediated G1/S arrest and apoptosis in 5FU resistant carcinoma cell lines.

J. Mirjolet, M. Barberi-Heyob, C. Didelot, 2003, International journal of oncology.

Evaluation and validation of HPV real-time PCR assay for the detection of HPV DNA in oral cytobrush and FFPE samples

A. Leroux, J. Salleron, J. Merlin, 2018, Scientific Reports.

Modulation by palmitoyl‐carnitine of calcium activated, phospholipid‐dependent protein kinase activity and inhibition of melanoma cell growth

C. Ramacci, P. Nabet, M. Matrat, 1988, The British journal of dermatology.

Additional value of EGFR downstream signaling phosphoprotein expression to KRAS mutation for response prediction to cetuximab in colorectal cancer (CRC)

A. Lièvre, P. Laurent-Puig, F. Penault-Llorca, 2008 .

P53 potentiates PTEN-mediated inhibition of EGFR downstream signaling pathway by cetuximab in prostate cancer cells

J. Merlin, C. Ramacci, S. Marchal, 2008 .